2023-10-30 10:16:00
Zuellig Pharma announced that it safely delivered the flu vaccine for the 2023 influenza national vaccination support project to medical institutions through the cold chain vaccine delivery system. The photo is an image of the company’s cold chain vaccine delivery. © Zuellig Pharma
Zuellig Pharma Korea announced on the 30th that it had safely delivered the flu vaccine for the 2023 influenza national vaccination support project to medical institutions.
As influenza continues to spread this year and vaccination has become more important than any other year, the government is providing free influenza vaccination for children, pregnant women, and the elderly from last September to April 30 of next year. Free flu vaccinations, as part of the 2023 influenza national vaccination support project, began sequentially on the 20th of last month, and flu vaccinations for the elderly are also currently in full swing. Zuellig Pharma Korea was responsible for delivering flu vaccines, which accounted for approximately 33% of the total volume of the support project.
Because the flu vaccine is sensitive to temperature, it must be delivered using a cold chain system from storage to delivery to medical institutions and patients.
Zuellig Pharma said, “We completed safe delivery to more than 7,000 domestic medical institutions within the target time through the excellent cold chain system and know-how in national business operation accumulated over a long period of time.”
The company explained that it has built a system to record real-time storage temperature using automatic temperature and electronic temperature recording devices in cold chain transportation and to monitor temperature during delivery. In addition, the company said that when using a transport container, it is equipped with a cold chain specialized refrigerant that controls exposure to room temperature and applies eZCooler technology that can maintain temperature for 48 hours.
Marc Franck, CEO of Zuellig Pharma Korea, said, “We are very pleased to have successfully completed the delivery of the flu vaccine to medical institutions for this national vaccination support project.” He added, “Participation in this vaccine support project is an opportunity to improve accessibility to healthcare.” “I think it was perfectly consistent with Zuellig Pharma’s vision,” he said.
He added, “In the future, Zuellig Pharma will continue to provide the highest quality healthcare solution services that put customers and patients first.”
1698705358
#약업신문Zuellig #Pharma #completes #delivery #flu #vaccine #influenza #national #vaccination #support #project
